Skip to content

A study to see if the product makes your skin appear younger

To evaluate the efficacy of the test product in providing Anti- Ageing Benefits in Healthy Human Volunteers - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064059
Enrollment
38
Registered
2024-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vegan Proteoglycan Essence: Twice a day, to be applied for 4 weeks for the entire face Control Intervention1: NA: NA

Sponsors

Ichimaru Pharcos Co Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects in the age group of 20-55 years (both ages inclusive). 2. Subject presenting at least 2 well defined dark spots of PIH/Acne/Age spots on either side of the face. 3. Subject identified for fine lines of score 4 and above and wrinkles of score 2 and above 4. Subjects with skin phototype III to V. (10% of the subjects to be phototype V). 5. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist. 6. Subject who agrees not to use any other product/treatment/home remedy/ except the provided product on their face during the study period other than the test product.

Exclusion criteria

Exclusion criteria: 1.Subject with any other signs of significant local irritation or skin disease. 2. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data. 3. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year. 4. Subjects undergoing any treatment of any skin condition on their face. 5. Subjects not willing to discontinue other topical facial products. 6. Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewelry or anything else. 7. Subjects who are pregnant and lactating (Self- declared). 8. Subject who has participated in a similar clinical investigation in the past one month.

Design outcomes

Secondary

MeasureTime frame
1. To evaluate dermatological safety and tolerability of the test product for the entire study duration Timepoint: Baseline, 72hours, week 2 and week 4

Primary

MeasureTime frame
1. Improvement in skin firmness or elasticity in comparison to baseline at different timepoints. 2. Improvement in Wrinkles, Fine lines and Post Inflammatory Hyperpigmentation (Dark Spots) in comparison to Baseline at different timepoints. 3. Improvement in hydration in comparison to untreated site and Baseline at different timepoints 4. Improvement in the skin color in comparison to baseline at different timepoints.Timepoint: Baseline, 72hours, week 2 and week 4

Countries

India

Contacts

Public ContactDr Mukesh Ramnane

MS Clinical Research Pvt Ltd

mukesh.ramnane@msclinical.com09620621625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026